BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 34 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,217,394 | +42.9% | 14,404,000 | 0.0% | 0.45% | +40.7% |
| Q2 2023 | $11,346,287 | +6.3% | 14,404,000 | 0.0% | 0.32% | +8.2% |
| Q1 2023 | $10,673,364 | +62.3% | 14,404,000 | -1.4% | 0.29% | +74.4% |
| Q4 2022 | $6,574,950 | -24.8% | 14,611,000 | 0.0% | 0.17% | -24.0% |
| Q3 2022 | $8,749,000 | +8.1% | 14,611,000 | 0.0% | 0.22% | +12.8% |
| Q2 2022 | $8,091,000 | -5.2% | 14,611,000 | 0.0% | 0.20% | +161.3% |
| Q1 2022 | $8,533,000 | -20.8% | 14,611,000 | 0.0% | 0.08% | -15.7% |
| Q4 2021 | $10,771,000 | -46.7% | 14,611,000 | 0.0% | 0.09% | -53.2% |
| Q3 2021 | $20,195,000 | -16.0% | 14,611,000 | 0.0% | 0.19% | -15.9% |
| Q2 2021 | $24,035,000 | +20.3% | 14,611,000 | +21.0% | 0.23% | +54.8% |
| Q1 2021 | $19,978,000 | – | 12,076,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 17,000,000 | $16,407,550 | 4.62% |
| BRAIDWELL LP | 114,338,000 | $109,764,480 | 3.47% |
| Castle Creek Arbitrage, LLC | 10,000,000 | $9,635,000 | 2.27% |
| ARISTEIA CAPITAL, L.L.C. | 67,223,000 | $64,534,080 | 1.74% |
| Graham Capital Management, L.P. | 55,529,000 | $53,481,723 | 1.26% |
| 683 Capital Management, LLC | 14,750,000 | $14,186,550 | 1.10% |
| TFG Asset Management GP Ltd | 5,850,000 | $5,622,500 | 1.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,875,000 | $21,039,375 | 0.87% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,421,000 | $32,084,160 | 0.75% |
| Context Capital Management, LLC | 6,110 | $5,858 | 0.47% |